2025 年 1 月 24 日，雅本化学股份有限公司（以下简称"公司"）第五届 董事会第二十三次（临时）会议和第五届监事会第二十二次（临时）会议审议 通过了《关于公司为子公司提供担保及子公司互相担保的议案》。为满足子公 司的经营发展需要，公司同意为全资子公司上海雅本化学有限公司（以下简称 "上海雅本"）办理银行授信等业务提供担保。具体内容详见公司于 2025 年 1 月 25 日在巨潮资讯网上披露的《关于公司为子公司提供担保及子公司互相担保 的公告》（公告编号：2025-008）。2025 年 2 月 24 日，公司 2025 年第一次临 时股东大会审议通过了上述议案。 二、担保的进展情况 证券代码：300261 证券简称：雅本化学 公告编号：2025-072 雅本化学股份有限公司 关于为子公司提供担保的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、担保情况概述 1、上海雅本 公司名称：上海雅本化学有限公司 为满足日常经营发展需要，上海雅本向宁波银行股份有限公司苏州分行 （以下简称"宁波银行苏州分行"）申请了不超过人民币 8,000 万元的授信额 ...

Core Points - Yabao Chemical announced that as of the date of the announcement, the total amount of external guarantees provided by the company is RMB 1.682 billion, accounting for 83.81% of the company's most recent audited net assets [2] - The cumulative balance of external guarantees provided by the company, which corresponds to the loans secured by these guarantees, is RMB 619.36 million, representing 30.86% of the company's most recent audited net assets [2] - All guarantees mentioned are provided for subsidiaries within the consolidated financial statements, with no overdue guarantees or guarantees involving litigation [2] - The company and its subsidiaries do not have any violations regarding guarantees or other guarantees for entities outside the consolidated financial statements [2]

证券代码：300261 证券简称：雅本化学 公告编号：2025-071 2025 年 1 月 24 日，雅本化学股份有限公司（以下简称"公司"）第五届 董事会第二十三次（临时）会议和第五届监事会第二十二次（临时）会议审议 通过了《关于公司为子公司提供担保及子公司互相担保的议案》。为满足子公 司的经营发展需要，公司同意为全资子公司上海雅本化学有限公司（以下简称 "上海雅本"）、南通雅本化学有限公司（以下简称"南通雅本"）办理银行 授信等业务提供担保。具体内容详见公司于 2025 年 1 月 25 日在巨潮资讯网上 披露的《关于公司为子公司提供担保及子公司互相担保的公告》（公告编号： 2025-008）。2025 年 2 月 24 日，公司 2025 年第一次临时股东大会审议通过了 上述议案。 2025 年 6 月 16 日，公司第六届董事会第四次（临时）会议和第六届监事 会第四次（临时）会议审议通过了《关于全资子公司向银行申请项目贷款并由 公司提供担保的议案》，公司同意为南通雅本申请银行项目贷款提供担保，担 保方式为连带责任保证担保，额度不超过人民币 2,500 万元，借款期限不超过 36 个月，主要用于支付项 ...

Group 1 - The company Yabao Chemical (300261) stated on September 15 that its NMN products have not applied for EFSA certification [1]

Group 1 - The core viewpoint of the article highlights that Amino Chemicals Limited (ACL), a subsidiary of Yabao Chemical, has maintained stable operations over the years [1] - For the first half of 2025, ACL achieved operating revenue of 30.4416 million yuan [1]

Company Overview - Yabao Chemical Co., Ltd. is located in Taicang Port Development Zone, Jiangsu Province, and was established on January 13, 2006, with its listing date on September 6, 2011 [2] - The company specializes in the research, development, production, and sales of pesticide intermediates and pharmaceutical intermediates [2] - The revenue composition includes pesticide intermediates (69.58%), pharmaceutical intermediates (21.73%), other (4.15%), environmental products (2.85%), and specialty chemicals (1.70%) [2] Stock Performance - As of September 15, Yabao Chemical's stock price increased by 2.04% to 7.50 CNY per share, with a trading volume of 77.59 million CNY and a turnover rate of 1.12%, resulting in a total market capitalization of 7.23 billion CNY [1] - Year-to-date, the stock price has risen by 9.49%, with a recent 5-day increase of 0.27%, a 20-day decline of 6.37%, and a 60-day increase of 3.45% [2] Financial Performance - For the period from January to June 2025, Yabao Chemical achieved a revenue of 662 million CNY, representing a year-on-year growth of 12.31% [2] - The net profit attributable to shareholders was -8.67 million CNY, showing a year-on-year increase of 83.33% [2] Shareholder Information - As of August 31, the number of shareholders was 54,900, a decrease of 2.31% from the previous period, with an average of 17,045 circulating shares per shareholder, an increase of 2.36% [2] - The company has distributed a total of 478 million CNY in dividends since its A-share listing, with 95.90 million CNY distributed over the past three years [3] Institutional Holdings - As of June 30, 2025, Hong Kong Central Clearing Limited is the fourth-largest circulating shareholder, holding 9.14 million shares as a new shareholder, while Southern CSI 1000 ETF has exited the top ten circulating shareholders [3]

证券代码：300261 证券简称：雅本化学 公告编号：2025-070 雅本化学股份有限公司 关于 2023 年员工持股计划预留份额分配的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 雅本化学股份有限公司(以下简称"公司")于 2025 年 9 月 5 日召开了 2023 年 员工持股计划（以下简称"本次员工持股计划"）2025 年第二次管理委员会会议， 审议通过了《关于公司 2023 年员工持股计划预留份额分配的议案》，同意公司对本 次员工持股计划预留份额进行分配。根据《雅本化学股份有限公司 2023 年员工持股 计划（草案修订稿）》（以下简称"《员工持股计划（草案修订稿）》"）及其摘 要、《雅本化学股份有限公司 2023 年员工持股计划管理办法（修订稿）》（以下简 称"《管理办法（修订稿）》"）的规定，本次预留份额分配事项在 2023 年员工持 股计划管理委员会审批权限范围内，无需提交公司董事会、股东会审议。现将有关 情况公告如下： 一、本次员工持股计划的实施进展 （一）公司于2023年8月24日召开了第五届董事会第十一次会议和第五届监事会 第十 ...

三、其他说明 证券代码：300261 证券简称：雅本化学 公告编号：2025-069 雅本化学股份有限公司 关于控股股东部分股份质押展期的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 雅本化学股份有限公司（以下简称"公司"）近日接到控股股东宁波雅本控 股有限公司（以下简称"宁波雅本"）的通知，宁波雅本将其持有的部分公司股 份办理了股份质押展期业务，具体事项如下： | | 是否为控 | | 占其 | 占公 | | 是否 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | 股股东或 | 本次股份 | 所持 | 司总 | 是否 | 为补 | 质押起 | 质押到 | | 展期后 | | 质权 | 质押 | | 名称 | 第一大股 | 质押数量 | 股份 | 股本 | 为限 | 充质 | 始日 | 期日 | | 到期日 | | 人 | 用途 | | | 东及其一 | （股） | 比例 | 比例 | 售股 ...

Core Viewpoint - Yabao Chemical Co., Ltd. announced that its controlling shareholder, Ningbo Yabao Holdings Co., Ltd., has extended the pledge of part of its shares, involving 37.97 million shares, which accounts for 14.73% of the shares held by Ningbo Yabao and 3.94% of the total share capital of the company [1] Summary by Relevant Sections - **Share Pledge Details** - The share pledge extension involves 37.97 million shares, representing 14.73% of the shares held by Ningbo Yabao and 3.94% of the company's total share capital [1] - The pledge is secured by Hongta Securities Co., Ltd., and the purpose is for financing and supplementing the pledge [1] - **Cumulative Pledge Status** - As of the announcement date, Ningbo Yabao and its concerted parties have cumulatively pledged 167.6 million shares, which accounts for 48.28% of their held shares and 17.40% of the company's total share capital [1] - **Risk Assessment** - The company stated that the controlling shareholder and its concerted parties have good creditworthiness, and the pledge risk is controllable, indicating that it will not lead to a change in actual control of the company or affect its operations [1]

Group 1 - The core viewpoint of the news is that Yabao Chemical has shown a decline in stock price and trading volume, with specific details on financing and stockholder changes [1][2][3] - On September 9, Yabao Chemical's stock fell by 1.20%, with a trading volume of 112 million yuan. The financing buy-in amount was 11.98 million yuan, while the net financing buy-in was 3.23 million yuan [1] - As of September 9, the total balance of margin trading for Yabao Chemical was 240 million yuan, with a financing balance of 239 million yuan, accounting for 3.36% of the circulating market value, which is below the 50th percentile level over the past year [1] Group 2 - As of August 31, the number of shareholders for Yabao Chemical was 54,900, a decrease of 2.31% from the previous period, while the average circulating shares per person increased by 2.36% to 17,045 shares [2] - For the first half of 2025, Yabao Chemical achieved an operating income of 662 million yuan, a year-on-year increase of 12.31%, while the net profit attributable to the parent company was -8.67 million yuan, reflecting an increase of 83.33% year-on-year [2] - Since its A-share listing, Yabao Chemical has distributed a total of 478 million yuan in dividends, with 95.90 million yuan distributed in the last three years [3]